Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)

August 20, 2025 5:44 AM EDT Send to a Friend
Laidlaw analyst Yale Jen reiterated a Buy rating and $110.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst comments "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login